Abstract
Heart failure (HF) presents with a wide spectrum of disease severity and with a broad risk of associated morbidity and mortality. Identification of individuals at high risk for HF death is important for assessment of candidacy for heart transplantation and mechanical circulatory assistance and, more broadly, for guiding pharmaceutical, surgical, or palliative interventions. In this article, we review and compare several of the HF risk prediction tools currently available, highlighting their clinical utilities and potential shortcomings. Risk prediction tools must be carefully selected, recognizing that their accuracy is likely to be greatest when used in patients most similar to those from whom the tool was developed. As HF is a dynamic condition, serial risk assessment at regular intervals and as patient clinical status changes is warranted, although clinical evidence to support this practice is limited.
Similar content being viewed by others
References and Recommended Reading
American Heart Association: Heart Disease and Stroke Facts, 2006 Update. Dallas: American Heart Association; 2006.
US Department of Health and Human Services, National Center for Health Statistics, National Hospital Discharge Survey, 2004 [computer file]. Hyattsville: US Department of Health and Human Services, National Center for Health Statistics; 2006.
Rose EA, Gelijns AC, Moskowitz AJ, et al.: Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. (REMATCH) study group. Longterm use of a left ventricular assist device for end stage heart failure. N Engl J Med 2001, 345:1435–1443.
Cohn JN, Tognoni G, Valsartan Heart Failure Trial Investigators: A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001, 345:1667–1675.
Eichhorn E: Prognostic determination in heart failure. Am J Med 2001, 110:14S–35S.
Fonarow GC, Adams KF, Abraham WT, et al.: Risk stratification for in-hospital mortality in acutely decompensated heart failure. Classification and regression tree analysis. JAMA 2005, 293:572–580.
Rohde LE, Goldraich L, Polanczyk CA, et al.: A simple clinically based predictive rule for heart failure in-hospital mortality. J Card Fail 2006, 12:587–593.
Lee DS, Austin PC, Rouleau JL, et al.: Predicting mortality among patients hospitalized for heart failure. Derivation and validation of a clinical model. JAMA 2003, 290:2581–2587.
Aaronson KD, Schawrtz JS, Chen TM, et al.: Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997, 95:2660–2667.
Levy WC, Mozaffarian D, Linker DT, et al.: The Seattle heart failure model. Prediction of survival in heart failure. Circulation 2006, 113:1424–1433.
American Heart Association: Heart Disease and Stroke Statistics-2006 Update. Dallas: American Heart Association; 2006.
Baker DW, Chin MH, Cinquegrani AF: ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. J Am Coll Cardiol 2001, 38:2101–2113.
Taylor DO, Edwards LB, Boucek MM, et al.: Registry for the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report-2005. J Heart Lung Transplant 2005, 24:945–955.
Levy D, Kenchaiah S, Larson MG, et al.: Long term trends in the incidence of and survival with heart failure. N Engl J Med 2002, 347:1397–1402.
Corra U, Mezzani A, Bosimini E, Giannuzzi P: Cardiopulmonary exercise testing and prognosis in chronic heart failure: a prognosticating algorithm for the individual patient. Chest 2004, 126:942–950.
Clark AL: Exercise and heart failure: assessment and treatment. Heart 2006, 92:699–703.
Mancini DM, Eisen H, Kussmaul W et al.: Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991, 83:778–786.
Stelken AM, Younis LT, Jennison SH, et al.: Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol 1996, 27:345–352.
Osman AF, Mehra MR, Lavie CJ, et al.: The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol 2000, 36:2126–2131.
Chua TP, Ponikowski P, Harrington D, et al.: Clinical correlates and prognostic significance of the ventilatory response to exercise in CHF. J Am Coll Cardiol 1997, 29:1585–1590.
Pohwani AL, Murali S, Matheir MM, et al.: Impact of β-blocker therapy on functional capacity criteria for heart transplant listing. J Heart Lung Transplant 2003, 22:78–86.
Koelling TM, Joseph S, Aaronson KD: Heart Failure Survival Score continues to predict clinical outcomes in patients with heart failure receiving β-blockers. J Heart Lung Transplant 2004, 23:1414–1422.
Butler J, Khadim G, Paul KM, et al.: Selection of patients for heart transplantation in the current era of heart failure therapy. J Am Coll Cardiol 2004, 43:787–793.
Packer M, O’Connor CM, Ghali JK, et al.: Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996, 335:1107–1114.
Lund LH, Aaronson KD, Mancini DM: Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure. Am J Cardiol 2005, 95:734–741.
Lietz K, Long J, Kfoury G, et al.: Risk score to predict survival to hospital discharge after left-ventricular assist device (LVAD) implantation as destination therapy (DT) [abstract 010]. J Card Fail 2006, 12(Suppl 1):S4.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matthews, J.C., Dardas, T.F. & Aaronson, K.D. Heart transplantation: Assessment of heart failure mortality risk. Curr Heart Fail Rep 4, 103–109 (2007). https://doi.org/10.1007/s11897-007-0008-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11897-007-0008-3